Concetta Rafaniello
- Toxicology top 0.5%
- Pharmacovigilance and Adverse Drug Reactions 19
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research 9
- COVID-19 Clinical Research Studies 9
-
- Diabetes Treatment and Management 11
- Pharmacology top 5%
- Drug-Induced Adverse Reactions 12
- Oncology top 10%
-
- Pharmaceutical studies and practices 13
-
- Heart Failure Treatment and Management 6
-
- Metabolism, Diabetes, and Cancer 6
- Co-authors
- Annalisa CapuanoLiberata SportielloCristina ScavoneFrancesco RossiAnnamaria MascoloLiberato BerrinoGabriella di MauroKatherine Esposito
- Journals
- SHILAP Revista de lepidopterología (4 papers)PLoS ONE (2 papers)Scientific Reports (1 paper)
In The Last Decade
Concetta Rafaniello
95 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 131
- Toxicology 252
- Infectious Diseases 372
- Endocrinology, Diabetes and Metabolism 318
- Pharmacology 286
- Oncology 438
Countries citing papers authored by Concetta Rafaniello
This map shows the geographic impact of Concetta Rafaniello's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Concetta Rafaniello with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Concetta Rafaniello more than expected).
Fields of papers citing papers by Concetta Rafaniello
This network shows the impact of papers produced by Concetta Rafaniello. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Concetta Rafaniello. The network helps show where Concetta Rafaniello may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Concetta Rafaniello, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 4 | |
| 3 | Conducting and interpreting disproportionality analyses derived from spontaneous reporting systemsbreakdown → | 2024 | 66 |
| 4 | 2023 | 5 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 11 | |
| 7 | 2023 | 2 | |
| 8 | 2022 | 24 | |
| 9 | 2022 | 21 | |
| 10 | 2021 | 33 | |
| 11 | 2020 | 32 | |
| 12 | 2020 | 7 | |
| 13 | 2020 | 199 | |
| 14 | 2020 | 11 | |
| 15 | 2019 | 7 | |
| 16 | Adverse drug reactions and gender differences: what changes in drug safety? | 2019 | 4 |
| 17 | 2018 | 15 | |
| 18 | Incretin-based therapies and cancer risk: a review of recent literature safety data | 2016 | 2 |
| 19 | 2012 | 27 | |
| 20 | Cardiorespiratory effects of change in posture after spinal anesthesia with hyperbaric bupivacaine. | 2011 | 6 |
About Concetta Rafaniello
Concetta Rafaniello is a scholar working on Toxicology, Applied Microbiology and Biotechnology and Family Practice, having authored 98 papers that have together received 2.2k indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (19 papers), Pharmaceutical studies and practices (13 papers), Drug-Induced Adverse Reactions (12 papers), Diabetes Treatment and Management (11 papers), SARS-CoV-2 and COVID-19 Research (9 papers), COVID-19 Clinical Research Studies (9 papers), Heart Failure Treatment and Management (6 papers) and Metabolism, Diabetes, and Cancer (6 papers). The work is most often cited by research in Toxicology (252 citations), Infectious Diseases (372 citations) and Endocrinology, Diabetes and Metabolism (318 citations). Concetta Rafaniello has collaborated with scholars based in Italy, Denmark and Norway. Frequent co-authors include Annalisa Capuano, Liberata Sportiello, Cristina Scavone, Francesco Rossi, Annamaria Mascolo, Liberato Berrino, Gabriella di Mauro, Katherine Esposito, Dario Giugliano and Francesco Rossi. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.